{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:01:08Z","timestamp":1776272468127,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82174020"],"award-info":[{"award-number":["82174020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03924-y","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:16:29Z","timestamp":1744618589000},"page":"3949-3964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptome analysis of key genes and pathways associated with cisplatin resistance in oral squamous cell carcinoma Cal27 cells"],"prefix":"10.1007","volume":"27","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiayang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengtian","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1770-0639","authenticated-orcid":false,"given":"Xiaohong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"3","key":"3924_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/ijdr.ijdr_157_22","volume":"33","author":"FM Selvaraj","year":"2022","unstructured":"Selvaraj FM, Joseph AP, Varun BR, Mony V, Siva Kumar TT. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa. Ind J Dent Res. 2022;33(3):282\u20136. https:\/\/doi.org\/10.4103\/ijdr.ijdr_157_22.","journal-title":"Ind J Dent Res"},{"issue":"5","key":"3924_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38467","volume":"15","author":"V Srinivasan","year":"2023","unstructured":"Srinivasan V, Shyam N, Kumar GK, Narayen V, Konda P, Swetha Rani K. A Comparison of Podoplanin Expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. Cureus. 2023;15(5): e38467. https:\/\/doi.org\/10.7759\/cureus.38467.","journal-title":"Cureus"},{"issue":"9","key":"3924_CR3","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.3390\/ijms21093388","volume":"21","author":"P Economopoulou","year":"2020","unstructured":"Economopoulou P, Kotsantis I, Psyrri A. Special issue about head and neck cancers: HPV positive cancers. Int J Mole Sci. 2020;21(9):3388.","journal-title":"Int J Mole Sci"},{"issue":"4","key":"3924_CR4","doi-asserted-by":"publisher","first-page":"101269","DOI":"10.1016\/j.bjorl.2023.03.006","volume":"89","author":"R Wiengnon","year":"2023","unstructured":"Wiengnon R, Chakkabat C, Tangjaturonrasme N, Rawangban W. Imaging nodal volume and survival in oral tongue cancer with cervical lymph node metastasis. Braz J Otorhinolaryngol. 2023;89(4):101269. https:\/\/doi.org\/10.1016\/j.bjorl.2023.03.006.","journal-title":"Braz J Otorhinolaryngol"},{"key":"3924_CR5","doi-asserted-by":"publisher","first-page":"894978","DOI":"10.3389\/fonc.2022.894978","volume":"12","author":"Z Xu","year":"2022","unstructured":"Xu Z, Peng J, Zeng X, Xu H, Chen Q. High-accuracy oral squamous cell carcinoma auxiliary diagnosis system based on efficientnet. Front Oncol. 2022;12:894978. https:\/\/doi.org\/10.3389\/fonc.2022.894978.","journal-title":"Front Oncol"},{"issue":"5","key":"3924_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4252\/wjsc.v15.i5.438","volume":"15","author":"P Joshi","year":"2023","unstructured":"Joshi P, Waghmare S. Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. World J Stem Cells. 2023;15(5):438\u201352. https:\/\/doi.org\/10.4252\/wjsc.v15.i5.438.","journal-title":"World J Stem Cells"},{"issue":"1","key":"3924_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-022-00210-3","volume":"15","author":"L Liang","year":"2023","unstructured":"Liang L, Li Y, Ying B, Huang X, Liao S, Yang J, Liao G. Mutation-associated transcripts reconstruct the prognostic features of oral tongue squamous cell carcinoma. Int J Oral Sci. 2023;15(1):1. https:\/\/doi.org\/10.1038\/s41368-022-00210-3.","journal-title":"Int J Oral Sci"},{"issue":"7","key":"3924_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/annonc\/mdp573","volume":"21","author":"A Paccagnella","year":"2010","unstructured":"Paccagnella A, Ghi MG, Loreggian L, Buffoli A, Koussis H, Mione CA, Bonetti A, Campostrini F, Gardani G, Ardizzoia A, Dondi D, Guaraldi M, Cavallo R, Tomio L, Gava A, Gruppo di Studio Tumori della Testa e del Collo XRP 6976 F\/2501 Study. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol. 2010;21(7):1515\u201322. https:\/\/doi.org\/10.1093\/annonc\/mdp573.","journal-title":"Ann Oncol"},{"issue":"3","key":"3924_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/ijms23031532","volume":"23","author":"S Dasari","year":"2022","unstructured":"Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci. 2022;23(3):1532. https:\/\/doi.org\/10.3390\/ijms23031532.","journal-title":"Int J Mol Sci"},{"key":"3924_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/bs.acr.2021.03.008","volume":"152","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ye ZW, Tew KD, Townsend DM. Cisplatin chemotherapy and renal function. Adv Cancer Res. 2021;152:305\u201327. https:\/\/doi.org\/10.1016\/bs.acr.2021.03.008.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"3924_CR11","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1038\/s41467-021-24845-8","volume":"12","author":"C Pan","year":"2021","unstructured":"Pan C, Kang J, Hwang JS, Li J, Boese AC, Wang X, Yang L, Boggon TJ, Chen GZ, Saba NF, Shin DM, Magliocca KR, Jin L, Kang S. Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1. Nat Commun. 2021;12(1):4960. https:\/\/doi.org\/10.1038\/s41467-021-24845-8.","journal-title":"Nat Commun"},{"key":"3924_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fphar.2020.00343","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L. The drug-resistance mechanisms of five platinum-based antitumor agents. Front Pharmacol. 2020;11:343. https:\/\/doi.org\/10.3389\/fphar.2020.00343.","journal-title":"Front Pharmacol"},{"issue":"11","key":"3924_CR13","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3390\/cancers12113482","volume":"12","author":"YJ Chen","year":"2020","unstructured":"Chen YJ, You GR, Lai MY, Lu LS, Chen CY, Ting LL, Lee HL, Kanno Y, Chiou JF, Cheng AJ. A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: from target identification to drug discovery. Cancers. 2020;12(11):3482. https:\/\/doi.org\/10.3390\/cancers12113482.","journal-title":"Cancers"},{"issue":"1","key":"3924_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jama.2022.22843","volume":"329","author":"S Ketkar","year":"2023","unstructured":"Ketkar S, Burrage LC, Lee B. RNA sequencing as a diagnostic tool. JAMA. 2023;329(1):85. https:\/\/doi.org\/10.1001\/jama.2022.22843.","journal-title":"JAMA"},{"key":"3924_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-0716-1795-3_4","volume":"2391","author":"N Gill","year":"2022","unstructured":"Gill N, Dhillon B. RNA-seq data analysis for differential expression. Meth Mole Biol (Clifton, NJ). 2022;2391:45\u201354. https:\/\/doi.org\/10.1007\/978-1-0716-1795-3_4.","journal-title":"Meth Mole Biol (Clifton, N.J.)"},{"issue":"9","key":"3924_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/0277-5379(88)90335-5","volume":"24","author":"J Gioanni","year":"1988","unstructured":"Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E, Ettore F, Formento P, Chauvel P, Lalanne CM. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol. 1988;24(9):1445\u201355. https:\/\/doi.org\/10.1016\/0277-5379(88)90335-5.","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"8","key":"3924_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/cbin.12169","volume":"48","author":"X Liu","year":"2024","unstructured":"Liu X, Li Z, Zhao Q, et al. Capsaicin reverses cisplatin resistance in tongue squamous cell carcinoma by inhibiting the Warburg effect and facilitating mitochondrial-dependent apoptosis via the AMPK\/AKT\/mTOR axis. Cell Biol Int. 2024;48(8):1097\u2013110. https:\/\/doi.org\/10.1002\/cbin.12169.","journal-title":"Cell Biol Int"},{"issue":"10","key":"3924_CR18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.14348\/molcells.2022.2014","volume":"45","author":"CS Cho","year":"2022","unstructured":"Cho CS, Jo DH, Kim JH, Kim JH. Establishment and characterization of carboplatin-resistant retinoblastoma cell lines. Mole Cells. 2022;45(10):729\u201337.","journal-title":"Mole Cells"},{"issue":"W1","key":"3924_CR19","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER20 for analysis of tumor-infiltrating immune cells. Nucl Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucl Acids Res"},{"issue":"18","key":"3924_CR20","doi-asserted-by":"publisher","first-page":"16851","DOI":"10.1007\/s00432-023-05372-z","volume":"149","author":"S Liu","year":"2023","unstructured":"Liu S, Zheng Y, Li S, Du Y, Liu X, Tang H, Meng X, Zheng Q. Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses. J Cancer Res Clin Oncol. 2023;149(18):16851\u201367. https:\/\/doi.org\/10.1007\/s00432-023-05372-z.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"3924_CR21","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.3390\/cancers13133235","volume":"13","author":"A Almangush","year":"2021","unstructured":"Almangush A, Bello IO, Heikkinen I, Hagstr\u00f6m J, Haglund C, Kowalski LP, Coletta RD, M\u00e4kitie AA, Salo T, Leivo I. Improving risk stratification of early oral tongue cancer with TNM-Immune (TNM-I) staging system. Cancers. 2021;13(13):3235. https:\/\/doi.org\/10.3390\/cancers13133235.","journal-title":"Cancers"},{"issue":"1","key":"3924_CR22","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-023-38318-7","volume":"14","author":"SJ Oh","year":"2023","unstructured":"Oh SJ, Lim JY, Son MK, Ahn JH, Song KH, Lee HJ, Kim S, Cho EH, Chung JY, Cho H, Kim H, Kim JH, Park J, Choi J, Hwang SW, Kim TW. TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway. Nat Commun. 2023;14(1):2691. https:\/\/doi.org\/10.1038\/s41467-023-38318-7.","journal-title":"Nat Commun"},{"issue":"1","key":"3924_CR23","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1038\/s41467-023-39035-x","volume":"14","author":"M Zhou","year":"2023","unstructured":"Zhou M, Wang J, Pan J, Wang H, Huang L, Hou B, Lai Y, Wang F, Guan Q, Wang F, Xu Z, Yu H. Nanovesicles loaded with a TGF-\u03b2 receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy. Nat Commun. 2023;14(1):3593. https:\/\/doi.org\/10.1038\/s41467-023-39035-x.","journal-title":"Nat Commun"},{"issue":"1","key":"3924_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","volume":"14","author":"J Linares","year":"2023","unstructured":"Linares J, Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, M\u00e9ndez A, Manero-Rup\u00e9rez N, Re DL, Rivas EI, Guiu M, Zwick M, Iglesias M, Martinez-Ciarpaglini C, Tarazona N, Varese M, Hernando-Momblona X, Ca\u00f1ellas-Socias A, Orrillo M, Garrido M, Saoudi N, Elez E, Calon A. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nat Commun. 2023;14(1):746. https:\/\/doi.org\/10.1038\/s41467-023-36334-1.","journal-title":"Nat Commun"},{"issue":"1","key":"3924_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/cancers15010061","volume":"15","author":"R Peiffer","year":"2022","unstructured":"Peiffer R, Boumahd Y, Gullo C, Crake R, Letellier E, Bellahc\u00e8ne A, Peulen O. Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer. Cancers. 2022;15(1):61. https:\/\/doi.org\/10.3390\/cancers15010061.","journal-title":"Cancers"},{"issue":"1","key":"3924_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10006-020-00929-5","volume":"26","author":"S Gupta","year":"2022","unstructured":"Gupta S, Nigam K, Srivastav RK, Ahmad MK, Mahdi AA, Sanyal S. Genetic polymorphism of tumor necrosis factor alpha (TNF-\u03b1) and tumor necrosis factor beta (TNF-\u03b2) genes and risk of oral pre-cancer and cancer in North Indian population. Oral Maxillofac Surg. 2022;26(1):33\u201343. https:\/\/doi.org\/10.1007\/s10006-020-00929-5.","journal-title":"Oral Maxillofac Surg"},{"issue":"12","key":"3924_CR27","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/s41419-017-0048-x","volume":"8","author":"Z Shen","year":"2017","unstructured":"Shen Z, Zhou R, Liu C, Wang Y, Zhan W, Shao Z, Liu J, Zhang F, Xu L, Zhou X, Qi L, Bo F, Ding Y, Zhao L. MicroRNA-105 is involved in TNF-\u03b1-related tumor microenvironment enhanced colorectal cancer progression. Cell Death Dis. 2017;8(12):3213. https:\/\/doi.org\/10.1038\/s41419-017-0048-x.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3924_CR28","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1038\/s41598-020-65145-3","volume":"10","author":"M Elahi","year":"2020","unstructured":"Elahi M, Rakhshan V. MED15, transforming growth factor beta 1 (TGF-\u03b21), Fc\u03b3RIII (CD16), and HNK-1 (CD57) are prognostic biomarkers of oral squamous cell carcinoma. Sci Rep. 2020;10(1):8475. https:\/\/doi.org\/10.1038\/s41598-020-65145-3.","journal-title":"Sci Rep"},{"issue":"7","key":"3924_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/jir.2020.0022","volume":"40","author":"X Mo","year":"2020","unstructured":"Mo X, Sun J, Xu L, Zhao N, Yan M, Li H, Qin P. Nucleosome assembly protein 1-Like 3 enhances cisplatin resistance of ovarian cancer cell by activating transforming growth factor-beta pathway. J Interf Cytok Res. 2020;40(7):333\u201340. https:\/\/doi.org\/10.1089\/jir.2020.0022.","journal-title":"J Interf Cytok Res"},{"issue":"1","key":"3924_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12967-022-03863-0","volume":"21","author":"K Yang","year":"2023","unstructured":"Yang K, Xie Y, Xue L, Li F, Luo C, Liang W, Zhang H, Li Y, Ren Y, Zhao M, Wang W, Liu J, Shen X, Zhou W, Fei J, Chen W, Gu W, Wang L, Li F, Hu J. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-\u03b21 in esophageal squamous cell carcinoma. J Transl Med. 2023;21(1):26. https:\/\/doi.org\/10.1186\/s12967-022-03863-0.","journal-title":"J Transl Med"},{"key":"3924_CR31","doi-asserted-by":"publisher","first-page":"810286","DOI":"10.3389\/fimmu.2021.810286","volume":"12","author":"ZW Liu","year":"2022","unstructured":"Liu ZW, Zhang YM, Zhang LY, Zhou T, Li YY, Zhou GC, Miao ZM, Shang M, He JP, Ding N, Liu YQ. Duality of interactions between TGF-\u03b2 and TNF-\u03b1 during tumor formation. Front Immunol. 2022;12:810286. https:\/\/doi.org\/10.3389\/fimmu.2021.810286.","journal-title":"Front Immunol"},{"issue":"8","key":"3924_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.it.2023.05.007","volume":"44","author":"J Huyghe","year":"2023","unstructured":"Huyghe J, Priem D, Bertrand MJM. Cell death checkpoints in the TNF pathway. Trends Immunol. 2023;44(8):628\u201343. https:\/\/doi.org\/10.1016\/j.it.2023.05.007.","journal-title":"Trends Immunol"},{"key":"3924_CR33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ibror.2020.08.005","volume":"9","author":"LM Yshii","year":"2020","unstructured":"Yshii LM, Manfiolli AO, Denadai-Souza A, Kinoshita PF, Gomes MD, Scavone C. Tumor necrosis factor receptor-associated factor 6 interaction with alpha-synuclein enhances cell death through the Nuclear Factor-kB pathway. IBRO reports. 2020;9:218\u201323. https:\/\/doi.org\/10.1016\/j.ibror.2020.08.005.","journal-title":"IBRO reports"},{"issue":"4","key":"3924_CR34","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.1080\/21655979.2022.2066758","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Cheng M, Gao P, Zhang X, Li G, Wang L, Qin L, Li H. GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-\u03b1 signaling pathway. Bioengineered. 2022;13(4):10944\u201355. https:\/\/doi.org\/10.1080\/21655979.2022.2066758.","journal-title":"Bioengineered"},{"issue":"41","key":"3924_CR35","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.3748\/wjg.v21.i41.11673","volume":"21","author":"M Yang","year":"2015","unstructured":"Yang M, Huang CZ. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21(41):11673\u20139. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11673.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3924_CR36","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900545","volume":"3","author":"HL Ngan","year":"2020","unstructured":"Ngan HL, Liu Y, Fong AY, Poon PHY, Yeung CK, Chan SSM, Lau A, Piao W, Li H, Tse JSW, Lo KW, Chan SM, Su YX, Chan JYK, Lau CW, Mills GB, Grandis JR, Lui VWY. MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling. Life Sci Allian. 2020;3(6): e201900545.","journal-title":"Life Sci Allian"},{"issue":"7_Supplement","key":"3924_CR37","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1158\/1538-7445.AM2023-6142","volume":"83","author":"R Alobaidi","year":"2023","unstructured":"Alobaidi R, Islam N, Zhang YR, Shamo MM, Allsup S, Simbulan-Rosenthal CM, Rosenthal DS. Inhibition of both MAPK and AKT pathways overcomes resistance of NRAS-mutant melanoma stem cells to apoptosis. Cancer Res. 2023;83(7_Supplement):6142\u201352.","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1007\/s12094-025-03998-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000}}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03924-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:36:40Z","timestamp":1758778600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03924-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3924"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03924-y","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct Figures 1 and 2, Figure 3 legend and an unit in the text.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12094-025-03998-8","URL":"https:\/\/doi.org\/10.1007\/s12094-025-03998-8","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involved the use of human surgical specimens obtained from patients. No animal experiments were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The study protocol was approved by the Ethics Committee of Peking University Health Science Center (IRB00001052 -\u200909087).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants prior to specimen collection.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable. This study utilized anonymized pathological specimens, and no individually identifiable data\/images are presented in the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}